Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest biopharmaceuticals Stories

2012-09-12 02:31:31

BALTIMORE, Sept. 12, 2012 /PRNewswire/ -- Gliknik Inc., a biopharmaceuticals company creating new therapies for cancer and immune / inflammatory disorders, today announced that its stradomers(TM) have clinical therapeutic potential, based upon newly published preclinical data in models of rheumatoid arthritis and thrombocytopenia (blood platelet deficiency). The research, which is part of a collaboration with the lab of Professor Scott Strome at the University of Maryland, Baltimore, was...

2012-08-29 22:23:45

LAUSANNE, Switzerland, August 30, 2012 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today presents the 'Debiopharm Group(TM) Life Sciences Award 2012' in collaboration with EPFL (Ecole polytechnique federale de Lausanne) to Professor Daniel D. Pinschewer for his outstanding research in the field of...

2012-08-03 02:22:52

MOUNTAIN VIEW, Calif., Aug. 3, 2012 /PRNewswire/ -- Based on its recent analysis of the recombinant expression systems market, Frost & Sullivan recognizes MicroProtein Technologies with the 2012 North American Frost & Sullivan Award for Technology Innovation for the development of its proprietary MPTxpress technology that provides a cost-effective production method for pharmaceutically and diagnostically relevant recombinant proteins, along with the highest percentage of yield in the...

2012-04-17 02:28:06

CAMBRIDGE, Mass., April 17, 2012 /PRNewswire/ -- Inspiration Biopharmaceuticals, Inc. announced today that it is joining with the World Federation of Hemophilia and the local and international bleeding disorders communities to observe World Hemophilia Day. Celebrated around the world on April 17, World Hemophilia Day is an annual event that seeks to increase public awareness of all inherited bleeding disorders and the challenges faced by this community. Approximately 400,000 people globally...

2012-04-16 18:20:33

CAMBRIDGE, Mass., April 17, 2012 /PRNewswire/ -- Inspiration Biopharmaceuticals, Inc. today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of IB1001, an intravenous recombinant factor IX (rFIX) protein for the treatment and prevention of bleeding in individuals with hemophilia B. Based on the terms of its agreement with Ipsen (Euronext: IPN; ADR: IPSEY), Inspiration will receive a $35 million milestone...

2011-10-19 07:38:00

STEVENAGE, England, October 19, 2011 /PRNewswire/ -- Stakeholder representative to guide development of UK's first open innovation bioscience campus Stevenage Bioscience Catalyst (SBC), the UK's first open innovation bioscience campus, is pleased to announce that Ian Tomlinson, Senior Vice President, Head of Biopharmaceuticals R&D and Worldwide Business Development at GlaxoSmithKline, has been appointed to its Board. In his role as GSK Representative Director,...

2011-10-03 07:30:00

BALTIMORE, Oct. 3, 2011 /PRNewswire/ -- Gliknik Inc., a biopharmaceuticals company creating new therapies for cancer and immune/inflammatory disorders, today announced that the National Cancer Institute (NCI) has awarded the company a Small Business Innovation Research (SBIR) Phase II contract for up to $1.5 million. With the funding, Gliknik will further advance its lead compounds from its first-in-class stradobody(TM) platform towards the clinic. "The NCI SBIR contract demonstrates...

2011-03-24 18:00:00

INGELHEIM, Germany, March 24, 2011 /PRNewswire/ -- Today Boehringer Ingelheim formally acquired Amgen's biopharmaceutical development and manufacturing facility in Fremont, California (USA). This acquisition involves leasing buildings, acquiring physical equipment and assuming manufacturing processes done at the Fremont site. The state-of-the-art facility currently employs more than 300 employees and consists of more than 200,000 square feet for laboratories, manufacturing and process...

2011-02-15 08:32:00

SAN DIEGO and INGELHEIM, Germany, Feb. 15, 2011 /PRNewswire/ -- Pfenex Inc., an industry leader in protein expression through the Pfenex Expression Technology(TM) platform and Boehringer Ingelheim International GmbH, a leading pharmaceutical company and global leader in biopharmaceutical contract development and manufacture, announced today that they have entered into a strategic agreement. It provides Boehringer Ingelheim with non-exclusive access to the Pfenex Expression Technology. Under...

2011-02-01 06:29:00

DALLAS, February 1, 2011 /PRNewswire/ -- - Biopharmaceutical Market Worldwide is Set for High Growth. The US biopharmaceutical market which has previously contributed 60% of world market share will witness a sudden growth spurt, triggered by a spate of policy changes, grants and the recent Health Care Reform Bill and AARC. However, as the rest of the world (ROW) markets are also set for high growth and hence the overall contribution of US market share in the world market...